Spots Global Cancer Trial Database for safety and efficacy
Every month we try and update this database with for safety and efficacy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With Obinutuzumab (GA101) in Relapsed/Refractory DLBCL and iNHL. | NCT02417285 | Lymphoma, Large... Lymphoma, Non-H... | Obinutuzumab CC-122 | 18 Years - | Celgene | |
| Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma | NCT02660710 | Diffuse Large B... HIV | R-CHOP | 18 Years - 60 Years | UNC Lineberger Comprehensive Cancer Center | |
| The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults | NCT05664009 | Fatigue Cancer, Treatme... | Redsenol-1 Plus Placebo | 18 Years - | Canada Royal Enoch Phytomedicine Co., Ltd. | |
| NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT05247957 | Safety and Effi... | CAR-NK cells | 10 Years - 75 Years | Hangzhou Cheetah Cell Therapeutics Co., Ltd | |
| A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy | NCT05660915 | Pancreatic Canc... Common Bile Duc... Periampullary C... | Intermediate ap... Standard approa... | 18 Years - | The First Affiliated Hospital of University of South China | |
| A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy | NCT05755594 | Pancreatic Canc... Common Bile Duc... Periampullary C... | Robot-assisted ... | 18 Years - 70 Years | The First Affiliated Hospital of University of South China | |
| A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD | NCT05755607 | Pancreatic Canc... Common Bile Duc... Periampullary C... | laparoscopic pa... Robot Pancreati... | 18 Years - | The First Affiliated Hospital of University of South China | |
| Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites | NCT05349552 | Radiotherapy Thoracic Cancer Safety and Effi... | stereotactic bo... | 18 Years - 80 Years | Peking University Third Hospital | |
| Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer | NCT06244537 | Safety and Effi... | MR-linac | 18 Years - | Sichuan Cancer Hospital and Research Institute | |
| Safety & Efficacy of Non-Invasive Procedures Using Ultrasound-Guided HIFU 'Sonotrip V20' in Symptomatic Uterine Fibroids | NCT05972642 | Myoma;Uterus | HIFU-treatment | 19 Years - | Seoul National University Hospital | |
| Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC | NCT04855331 | Borderline Rese... | Laparoscopic pa... Open pancreatod... | 18 Years - 80 Years | Fudan University | |
| The HEALS Project - Health Education and Active Living for Surviving Seniors | NCT01305044 | Cancer Survivor... Safety and Effi... Quality of Life | Tai Chi Chih Health Educatio... | 55 Years - 90 Years | University of Utah | |
| The HEALS Project - Health Education and Active Living for Surviving Seniors | NCT01305044 | Cancer Survivor... Safety and Effi... Quality of Life | Tai Chi Chih Health Educatio... | 55 Years - 90 Years | University of Utah | |
| A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) | NCT02997202 | Acute Myeloid L... | gilteritinib Placebo | 18 Years - | Astellas Pharma Inc | |
| Prevention and Treatment of Differentiation Syndrome in Patients With Acute Promyelocytic Leukemia | NCT04446806 | Safety and Effi... | Ruxolitinib | 18 Years - 70 Years | The First Affiliated Hospital of Soochow University | |
| Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer | NCT05277766 | Peritoneal Carc... Peritoneal Meta... Colorectal Canc... Small Bowel Can... Appendix Cancer Gastric Cancer Pancreatic Canc... Bile Duct Cance... | PIPAC with Nal-... | 18 Years - | University Hospital, Ghent |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
